{
    "clinical_study": {
        "@rank": "141128", 
        "acronym": "EuroCTO", 
        "arm_group": [
            {
                "arm_group_label": "Biolimus-eluting stent implantation", 
                "arm_group_type": "Active Comparator", 
                "description": "PCI of CTO using a Biomatrix drug-eluting stent system + optimal medical therapy."
            }, 
            {
                "arm_group_label": "Medical therapy", 
                "arm_group_type": "No Intervention", 
                "description": "Optimal medical therapy. Subsequent PCI only if symptoms of angina persist despite optimal medical therapy. At least 2 anti-anginal agents or the maximum tolerated anti-anginal therapy should be used before crossover. Medical therapy should include adequate ventricular rate-limiting medication (i.e. Beta-blocker or rate-limiting calcium antagonist) where appropriate."
            }
        ], 
        "brief_summary": {
            "textblock": "CTOs are common among patients with angina, and are detected in around 20% of patients\n      undergoing coronary angiography. Treatment of CTO has been found to constitute only 7% of\n      PCI practice on average. One of the reasons for the under-presentation of CTOs in PCI target\n      lesions is the lack of evidence-based medical data on treatment indications, and the\n      continued low level of accepted evidence for the treatment of CTOs by PCI in PCI guidelines.\n\n      Patients with a CTO represent patients with stable coronary artery disease. The COURAGE\n      trial comparing PCI with optimal medical therapy in stable coronary disease did not show a\n      difference in mortality or myocardial infarction between the two treatment options. However,\n      CTOs were not included in the COURAGE trial. But that trial did confirm the superiority of\n      PCI over OMT in controlling symptoms of angina, with a high cross-over rate to PCI. Whether\n      PCI for CTO is superior to OMT in reducing MACE in those patients with a large ischaemic\n      burden has never been tested in a randomized controlled trial.\n\n      While there is compelling evidence from registry studies of a clinical and prognostic\n      benefit following successful PCI of CTO compared with PCI failure, there has been no\n      randomized controlled trial of contemporary PCI using drug-eluting stents versus optimal\n      medical therapy. The COURAGE trial nuclear sub-study confirms both that prognosis is closely\n      related to the extent of residual ischaemia and that PCI is more effective in reducing\n      residual ischaemia than optimal medical therapy alone. This confirms earlier retrospective\n      data suggesting that the benefit of PCI is greatest in patients with moderate (10-20%) or\n      severe (>20%) ischaemia.\n\n      Study hypothesis: PCI with Biolimus eluting stent implantation plus OMT will be superior to\n      OMT alone in improving health status at 12-month follow-up, and will be noninferior with\n      respect to the composite of all cause death/ non fatal MI at 36-month follow up, in patients\n      with a CTO in an epicardial coronary artery >2.5 mm diameter and chronic stable angina with\n      evidence of ischemia and viability in the territory subtended by the CTO"
        }, 
        "brief_title": "A Randomized Multicentre Trial to Evaluate the Utilization of Revascularization or Optimal Medical Therapy for the Treatment of Chronic Total Coronary Occlusions", 
        "completion_date": {
            "#text": "March 2017", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Chronic Stable Angina", 
            "Dyspnea", 
            "Coronary Occlusion"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Dyspnea", 
                "Coronary Occlusion", 
                "Angina Pectoris"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  \u2265 18 years of age with written informed consent\n\n          -  CTO in native coronary artery\n\n          -  a) Stable angina, or b) myocardial ischaemia in a territory supplied by CTO, and c)\n             viability in akinetic myocardium (<50% transmural late enhancement on MRI or normal\n             resting perfusion scan)\n\n          -  CTO located in segments 1-3 (RCA), 6-7 (LAD), 11-12 (LCx)\n\n          -  target artery \u22652.5mm\n\n        Exclusion Criteria:\n\n          -  AMI or NSTE-ACS within 1 month\n\n          -  Significant untreated coronary stenosis in a territory other than CTO\n\n          -  Patients with MVD and significant non-CTO stenoses where it is deemed unsafe to treat\n             the non-CTO lesion first (e.g. Significant proximal LAD lesion with chronically\n             occluded RCA)\n\n          -  Patient unsuitable for 12 month dual anti-platelet therapy\n\n          -  Any exclusion criteria for PCI or DES\n\n          -  Pregnant or nursing patients and those who plan pregnancy in the period up to 1 year\n             following index procedure"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "1200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 1, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01760083", 
            "org_study_id": "2011-005905-64"
        }, 
        "intervention": {
            "arm_group_label": "Biolimus-eluting stent implantation", 
            "description": "Recanalization of chronic coronary artery occlusion and subsequent implantation of one or ore Biosensor stents", 
            "intervention_name": "Biolimus-eluting stent implantation", 
            "intervention_type": "Device", 
            "other_name": "Biosensors Biolimus-eluting stents of all sizes and lengths"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 1, 2013", 
        "link": {
            "description": "Sponsor European CTO Club e.V. (ECC)", 
            "url": "http://eurocto.eu"
        }, 
        "location": [
            {
                "contact": {
                    "last_name": "Jean-Louis Leymarie, MD", 
                    "phone": "33 (0)5 57 81 07 81"
                }, 
                "facility": {
                    "address": {
                        "city": "Bordeaux", 
                        "country": "France", 
                        "zip": "33074"
                    }, 
                    "name": "Clinique Saint-Augustin"
                }, 
                "investigator": {
                    "last_name": "Jean-Lois Leymarie, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Simone Elhadad, MD", 
                    "phone": "33 (0)1 64 30 76 22"
                }, 
                "facility": {
                    "address": {
                        "city": "Lagny", 
                        "country": "France", 
                        "zip": "77405"
                    }, 
                    "name": "CH de Lagny"
                }, 
                "investigator": {
                    "last_name": "Simon Elhadad, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Yves Louvard, MD", 
                    "phone": "33 (0)1 60 13 61 68"
                }, 
                "facility": {
                    "address": {
                        "city": "Massy", 
                        "country": "France", 
                        "zip": "91300"
                    }, 
                    "name": "Institut Hospitalier Jacques Cartier - ICPS"
                }, 
                "investigator": {
                    "last_name": "Yves Louvard, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Didier Tchetche, MD", 
                    "phone": "33 (0)5 62 21 31 31"
                }, 
                "facility": {
                    "address": {
                        "city": "Toulouse", 
                        "country": "France", 
                        "zip": "31076"
                    }, 
                    "name": "Clinique Pasteur"
                }, 
                "investigator": {
                    "last_name": "Didier Tchetche, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Nicolas Boudou, MD", 
                    "phone": "33 (0)5-61-32-26-65"
                }, 
                "facility": {
                    "address": {
                        "city": "Toulouse", 
                        "country": "France", 
                        "zip": "31076"
                    }, 
                    "name": "Rangueil university hospital"
                }, 
                "investigator": {
                    "last_name": "Nicolas Boudou, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bad Berka", 
                        "country": "Germany", 
                        "zip": "99438"
                    }, 
                    "name": "Zentralklinik Bad Berka"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bad Krozingen", 
                        "country": "Germany", 
                        "zip": "79189"
                    }, 
                    "name": "Herz-Zentrum Bad Krozingen"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "contact": {
                    "email": "n.reifart@reifart-partner.de", 
                    "last_name": "Nicolaus Reifart, MD PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Bad Soden", 
                        "country": "Germany", 
                        "zip": "65812"
                    }, 
                    "name": "Main Taunus Kliniken"
                }, 
                "investigator": {
                    "last_name": "Nicolaus Reifart, MD PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Gerald S Werner, MD", 
                    "phone": "4906151010706401"
                }, 
                "facility": {
                    "address": {
                        "city": "Darmstadt", 
                        "country": "Germany", 
                        "zip": "64283"
                    }, 
                    "name": "Klinikum Darmstadt"
                }, 
                "investigator": [
                    {
                        "last_name": "Hiller Moehlis, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Gerald S Werner, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wuppertal", 
                        "country": "Germany", 
                        "zip": "42117"
                    }, 
                    "name": "HELIOS Klinikum Wuppertal"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Alfredo R Galassi, MD PhD", 
                    "phone": "+39-095-7436210"
                }, 
                "facility": {
                    "address": {
                        "city": "Catania", 
                        "country": "Italy", 
                        "zip": "95126"
                    }, 
                    "name": "Cardiac Catheterization Laboratory and Cardiovascular Interventional Unit Cannizzaro Hospita"
                }, 
                "investigator": {
                    "last_name": "Alfredo R Galassi, MD PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Andrejs A Erglis, MD PhD", 
                    "phone": "+371 67 06 93 79"
                }, 
                "facility": {
                    "address": {
                        "city": "Riga", 
                        "country": "Latvia", 
                        "zip": "1002"
                    }, 
                    "name": "Latvian Center of Cardiology Pauls Stradins Clinical University Hospital"
                }, 
                "investigator": [
                    {
                        "last_name": "Andrejs A Erglis, MD PhD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Aigars Lismanis, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "zip": "08036"
                    }, 
                    "name": "Hospital Clinic Villaroel"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "zip": "08025"
                    }, 
                    "name": "Unidad de Cardiolog\u00eda Intervencionista Hospital de Sant Pau"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "contact": {
                    "email": "rumo@secardiologia.es", 
                    "last_name": "Ramon Rumoroso, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Galdakao", 
                        "country": "Spain", 
                        "zip": "48960"
                    }, 
                    "name": "Hospital Galdakao-Usansolo"
                }, 
                "investigator": {
                    "last_name": "Ramon Rumoroso, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28040"
                    }, 
                    "name": "Cardiovascular Institute - Hospital Clinico San Carlos"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "contact": {
                    "last_name": "David Hildick-Smith, MD", 
                    "phone": "'+44 1273 696955"
                }, 
                "facility": {
                    "address": {
                        "city": "Brighton", 
                        "country": "United Kingdom", 
                        "zip": "BN2 5BE"
                    }, 
                    "name": "Royal Sussex County Hospital - Brighton and Sussex University Hospitals"
                }, 
                "investigator": {
                    "last_name": "David Hildick-Smith, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "James Spratt, MD", 
                    "phone": "+44 131 536 1000"
                }, 
                "facility": {
                    "address": {
                        "city": "Edinburgh", 
                        "country": "United Kingdom", 
                        "zip": "EH16 4SA"
                    }, 
                    "name": "Royal Infirmary of Edinburgh"
                }, 
                "investigator": {
                    "last_name": "James Spratt, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Anthony Gershlick, MD PhD", 
                    "phone": "+44 7850 57 46 38"
                }, 
                "facility": {
                    "address": {
                        "city": "Leicester", 
                        "country": "United Kingdom", 
                        "zip": "LE3 9QP"
                    }, 
                    "name": "Department of Cardiovascular Sciences University of Leicester"
                }, 
                "investigator": {
                    "last_name": "Anthony Gershlick, MD PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Carlo Di Mario, MD PhD", 
                    "phone": "+44 207 351 8616"
                }, 
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom", 
                        "zip": "SW7 2AZ"
                    }, 
                    "name": "National Heart and Lung Institute Imperial College"
                }, 
                "investigator": {
                    "last_name": "Carlo Di Mario, MD PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "France", 
                "Germany", 
                "Italy", 
                "Latvia", 
                "Spain", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized Multicentre Trial to Evaluate the Utilization of Revascularization or Optimal Medical Therapy for the Treatment of Chronic Total Coronary Occlusions", 
        "other_outcome": {
            "description": "Economic assessment & cost efficacy", 
            "measure": "Health-economic analysis", 
            "safety_issue": "No", 
            "time_frame": "12 and 36 months"
        }, 
        "overall_official": {
            "affiliation": "Klinikum Darmstadt, Darmstadt Germany", 
            "last_name": "Gerald S Werner, MD PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "European Union: European Medicines Agency", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Seattle Angina Questionnaire and EQ-5D for health outcomes measurement", 
                "measure": "Quality of Life", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 12 months"
            }, 
            {
                "description": "Cumulative composite endpoint of  all-cause death, non-fatal MI at 3 years", 
                "measure": "Major cardiovascular events", 
                "safety_issue": "Yes", 
                "time_frame": "36 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01760083"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "All cause mortality Cardiac mortality Myocardial Infarction Any hospitalization due to cardiovascular events (angina, congestive heart failure, arrythmias)", 
                "measure": "Safety and efficacy endpoints", 
                "safety_issue": "Yes", 
                "time_frame": "12 and 36 months"
            }, 
            {
                "description": "Incl. periprocedural  enzyme leak (defined by CK increase >3 times ULN); pericprocedural MI (new Q-wave or STEMI); pericardial tamponade, need for urgent CABG, CIN, death within 30 days, proven periprocedural cerebrovascular events", 
                "measure": "Prcedural complications", 
                "safety_issue": "Yes", 
                "time_frame": "baseline upto 36 months"
            }, 
            {
                "description": "Need to cross from OMT to PCI in Group 2 (after escalation up to maximum tolerated anti-anginal therapy and persistent unequivocal symptoms)", 
                "measure": "Protocol adherence", 
                "safety_issue": "Yes", 
                "time_frame": "36 months"
            }, 
            {
                "description": "primary endpoint comparison in patients who did have a successful revascularization compared to those patients treated medically who had no subsequent PCI", 
                "measure": "Per protocol analysis", 
                "safety_issue": "Yes", 
                "time_frame": "36 months"
            }
        ], 
        "source": "Euro CTO Club", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "NHS Research and Development", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Biosensors International", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Asahi Intecc Co. Ltd.", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Euro CTO Club", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}